Histone Deacetylases: Anti-Angiogenic Targets in Cancer Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|10|8|898-913

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.10, Iss.8, 2010-12, pp. : 898-913

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Structure and Function of Histone Deacetylases: The Target for Anti-cancer Therapy

By  

Current Medicinal Chemistry, Vol. 15, Iss. 27, 2008-11 ,pp. : 2840-2849

Bentham Science Publishers

Access to resources Recommend Favorite

Target-based Anti-angiogenic Therapy in Breast Cancer

By  

Current Pharmaceutical Design, Vol. 18, Iss. 27, 2012-09 ,pp. : 4244-4257

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Angiogenic and Anti-Inflammatory Effects of Statins: Relevance to Anti-Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 5, Iss. 8, 2005-12 ,pp. : 579-594

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting class I histone deacetylases in cancer therapy

By Delcuve Geneviève P   Khan Dilshad H   Davie James R  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 1, 2013-01 ,pp. : 29-41

Informa Healthcare

Access to resources Recommend Favorite

Vascular Endothelial Growth Factor as an Anti-Angiogenic Target for Cancer Therapy

By  

Current Drug Targets, Vol. 11, Iss. 8, 2010-01 ,pp. : 1000-1017

Bentham Science Publishers

Access to resources Recommend Favorite